Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.
about
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactImmunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplastyLiver transplantatation- an overviewCyclosporine A impairs the macrophage reverse cholesterol transport in mice by reducing sterol fecal excretionCurrent status of immunosuppression in liver transplantationReconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesAlleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegenerationEffects of immunosuppressants after penetrating keratoplasty: meta-analysis of randomized controlled trials.Calcineurin Orchestrates Lateral Transfer of Aspergillus fumigatus during Macrophage Cell DeathCircadian variation of cytotoxicity and genotoxicity induced by an immunosuppressive agent "Mycophenolate Mofetil" in rats.Single-cell RNA sequencing reveals T helper cells synthesizing steroids de novo to contribute to immune homeostasis.mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.Immunosuppressant prograf® (tacrolimus) induces histopathological disorders in the peritubular tissue of rat testes.Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose.A novel library screen identifies immunosuppressors that promote osteoblast differentiation.Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer.Assessment of readiness for clinical decision support to aid laboratory monitoring of immunosuppressive care at U.S. liver transplant centersImmunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling.Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients.Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects.Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection.Quality of sleep and health-related quality of life in renal transplant recipients.Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia.Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice.Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case reportImmunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.Everolimus associated interstitial pneumonitis in a liver transplant patient.T-regulatory cell-mediated immune tolerance as a potential immunotherapeutic strategy to facilitate graft survivalEfficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular CarcinomaStructural alterations in the seminiferous tubules of rats treated with immunosuppressor tacrolimusAftercare for patients with transplanted organs.Identification of crassin acetate as a new immunosuppressant triggering heme oxygenase-1 expression in dendritic cellsPoor sleep in organ transplant recipients: self-reports and actigraphy.Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs.Treatment strategies for myasthenia gravis.Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?Association of immunosuppressant-induced protein changes in the rat kidney with changes in urine metabolite patterns: a proteo-metabonomic study.
P2860
Q22299128-932D9B92-C4EF-4943-A29F-E4BF1F540781Q24187740-7B5787B3-5CD7-4545-B78F-D22BA0DA2F52Q26863200-5420157B-CEBD-48AE-85F8-5F133C8B0EFCQ27309230-6E4F775C-FD63-4107-AD6A-BA920B80911AQ27694591-A0AE9ABB-B002-4C9A-9EA1-7072D56DC873Q28080994-77EBEA73-AFAF-4238-9CD0-F111E465138BQ28834138-3D2F228F-3F0C-4C73-BAD7-144B02E20B9BQ30467905-C1AAF6E6-7AFF-4016-9BE2-B13C1BDD0BACQ30829038-FE9CF08C-4AE7-4C25-B9B8-95B516B30F35Q33434301-8C2F922C-5A56-4085-84BD-C68227A60E11Q33691866-72366F3C-06BF-4DE7-8B68-B78E210EA360Q33749391-CB04E571-F339-47EA-AC74-30F8EC751EE1Q33811601-DD2B6EC8-CFD2-41F0-A152-99C58ADD8FA1Q33891750-22058609-F2F2-4D73-B6A2-B04A68DDD263Q34026264-50D0C1DC-1E43-4F1B-9F7C-D57EB3D4EB53Q34197280-4D8241ED-93A5-42C2-84E1-2A19B3FCFDBAQ34728470-4812FC39-09A7-4030-B9D1-1EBA208878AFQ34877263-16560EF4-2CA3-4341-85E2-5F965FD61CE3Q35570447-157892E9-60FD-4641-B9D6-234157D34F5DQ35836067-0CCB087E-4616-4448-8727-79A801EB4E94Q35987461-B4B57E6D-9DDE-419F-96A3-AAAA97CF86B0Q36069451-7F10EB78-9237-42FD-9B6C-7BA1C714FA18Q36227374-55FF8ABD-0CB3-4E9E-9BBC-024B7A6D2505Q36317889-EC916B62-46DD-4AD3-8A2F-92960D61D22EQ36446926-B4A3E985-ECE3-425A-8828-A6D9E4487FAFQ36447762-A8A6B2B0-8F97-4F86-BA28-4B4B04DA334EQ36499442-C08317E2-308E-4254-9D52-3099D9770B94Q36681070-6C180E31-87A5-4C1E-9C1E-8D31976E1A62Q36861712-A8082BD0-7C1F-4EDC-A221-9E1993BFE837Q37035159-D141D535-2264-428C-BB73-DB5624F1E4DDQ37059199-2D5FBC2A-B5B0-4E98-BA46-15C7E4F9F69EQ37066388-AB558F7E-51A6-4591-A7CB-C949C607A316Q37139218-BB158F08-722A-4E89-BB5E-F4977F47EE30Q37227156-5B1205A7-3116-4114-AD84-CEB4F7902E42Q37262498-9112C4F8-BE5E-40C5-BF7E-969DE171410FQ37374480-48B83F3A-3E56-44AB-A003-2B901B4B2966Q37440010-B2625B43-3CAD-4DB5-9CD7-5FC2A3A8A3F5Q37483922-0C11B66B-4855-4EE2-87B6-4496F7EBC581Q37622487-4671BB87-E372-49F0-9380-4ABF97C8AC66Q37639949-0BFECA9F-F3EF-4ACD-9C13-017FE8F10AA4
P2860
Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Immunosuppressive agents in so ...... tion and therapeutic efficacy.
@ast
Immunosuppressive agents in so ...... tion and therapeutic efficacy.
@en
Immunosuppressive agents in so ...... tion and therapeutic efficacy.
@nl
type
label
Immunosuppressive agents in so ...... tion and therapeutic efficacy.
@ast
Immunosuppressive agents in so ...... tion and therapeutic efficacy.
@en
Immunosuppressive agents in so ...... tion and therapeutic efficacy.
@nl
prefLabel
Immunosuppressive agents in so ...... tion and therapeutic efficacy.
@ast
Immunosuppressive agents in so ...... tion and therapeutic efficacy.
@en
Immunosuppressive agents in so ...... tion and therapeutic efficacy.
@nl
P1476
Immunosuppressive agents in so ...... ction and therapeutic efficacy
@en
P2093
Anna L Taylor
J Andrew Bradley
P356
10.1016/J.CRITREVONC.2005.03.012
P577
2005-10-01T00:00:00Z